BioWorld Asia

Aug. 27, 2003

NicOx, Merck Enter Agreement Around Nitric Oxide Compounds

PARIS - NicOx SA and Merck & Co. Inc. signed an agreement allowing Merck to evaluate certain nitric oxide-donating compounds under NicOx's intellectual property rights. (BioWorld International) Read More

German Health Care Legislation Could Set Back Biotech Sector

Research Group Grows UK's First Embryonic Stem Cell Line

Merlin Sets Up Shop In Finland, Evaluates Biotech Opportunities

Celltech Ends Development Of CDP 571 In Crohn's Indication

Agendia Planning Predictive Array Trials For Breast Cancer

Meristem Therapeutics Victim Of Terrorism' By Anti-GMO Activists

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

Businesspeople shaking hands, meeting with cityscape, charts

Deals and an M&A strengthen end-of-year numbers

BioWorld

Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...

Neutrophils put the brakes on fat loss

BioWorld Science

Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...